Skip to content

Trimas TRS Weighted-Average Discount Rate - Finance Leases

Weighted-Average Discount Rate - Finance Leases at other companies

West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
Chart Industries logo
Chart IndustriesGTLS

Other financials

Income statement

See full
Revenue$168.3M+10.4%
Gross profit$36.9M+12.3%
Operating income$6.9M-3.6%
Net income$800.8M+6,348%
EPS (diluted)$21.40+7,033%

Balance sheet

See full
Cash & equivalents$1.3B+3,904%
Total debt$439.9M-9.2%
Total equity$1.4B+111%
Total assets$2.3B+64.8%

Cash flow

See full
Operating cash flow-$19.4M-311%
CapEx$5.2M-59.7%
Free cash flow-$24.6M-556%

Valuation

See full
Market cap$1.56B+41.9%
Enterprise value$692.33M-65.6%
P/E1.7×-33.2×
P/S2.4×+0.6×

Profitability

See full
Gross margin-0.1%-2.1pp
Operating margin8%-1.0pp
Net margin137.3%+132pp
FCF margin7.3%+3.1pp

Returns & leverage

See full
Return on equity85.1%+80.4pp
Debt / equity0.3×-0.4×
Current ratio4.9×+2.0×

Where this comes from

Reported directly by Trimas in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent.

The official record: Trimas’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Trimas's weighted-average discount rate - finance leases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Trimas's weighted-average discount rate - finance leases?
Trimas (TRS) reported weighted-average discount rate - finance leases of $0.03 in Q1 2026.
How has Trimas's weighted-average discount rate - finance leases changed year-over-year?
Trimas's weighted-average discount rate - finance leases decreased by 0.0% year-over-year, from $0.03 to $0.03.
What is the long-term trend for Trimas's weighted-average discount rate - finance leases?
Over 2 years (2023 to 2025), Trimas's weighted-average discount rate - finance leases has grown at a 0.0% compound annual growth rate (CAGR), from $0.03 to $0.03.